<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21" class="p">The biological activities of lipopeptides have been reported in marine bacteria. Marine derived lipopeptide, surfactin from 
 <italic class="italic">B. circulans</italic> DMS-2 has potential antitumor activity against cancer cell lines HCT-15 (IC
 <sub class="sub">50</sub> 80 μg ml
 <sup class="sup">−1</sup>) and HT-29 (IC
 <sub class="sub">50</sub> 120 μg ml
 <sup class="sup">−1</sup>) (Sivapathasekaran et al. 
 <xref ref-type="bibr" rid="CR87" class="xref">2010</xref>). The lipopeptide BS produced by the marine 
 <italic class="italic">B. circulans</italic> has anti-adhesive activity against several potential pathogenic strains. It was seen that BS-mediated surface conditioning significantly decreased bacterial adhesion of pathogenic strains like 
 <italic class="italic">E. coli</italic>, 
 <italic class="italic">Micrococcus flavus</italic> and 
 <italic class="italic">Proteus vulgaris</italic> up to 89% at a concentration as low as 0.1 g/l showing its potential in biomedical applications (Das et al. 
 <xref ref-type="bibr" rid="CR13" class="xref">2009a</xref>). In another study a marine-derived 
 <italic class="italic">B. subtilis</italic> SDNS produced 
 <italic class="italic">ε</italic>-poly-
 <sc class="sc">l</sc>-lysine (
 <italic class="italic">ε</italic>-PL) which showed anti-cancer activity against human Hela S3 cell line (El-Sersy et al. 
 <xref ref-type="bibr" rid="CR25" class="xref">2012</xref>).
</p>
